No Data
No Data
Morgan Stanley Maintains Henry Schein(HSIC.US) With Sell Rating, Maintains Target Price $55
Morgan Stanley Keeps Their Sell Rating on Henry Schein (HSIC)
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC) and CSL (OtherCMXHF)
Here's What's Concerning About Henry Schein's (NASDAQ:HSIC) Returns On Capital
Henry Schein Sets Science-Based Emissions Reduction Targets for 2030 and 2050
IntelePeer Joins Henry Schein One API Exchange as an Authorized Integration Vendor